About Us Services Careers FAQ Contact Us 0
Home Biotechnology Therapeutic Drug Monitoring Market to Register at a CAGR of 10.2% By 2032
Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Technology (Immunoassays, Chromatography-Spectrometry), By Product (Consumables, Equipment), By Drug Class (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs), By End-User (Hospital, Diagnostic labs, Research and Academic Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI56015DR
Last Updated : April 22, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Therapeutic Drug Monitoring Market Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    6. U.S.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassays
          1. By Value
        3. Chromatography-Spectrometry
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Consumables
          1. By Value
        3. Equipment
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Antiepileptic Drugs
          1. By Value
        3. Antiarrhythmic Drugs
          1. By Value
        4. Immunosuppressant Drugs
          1. By Value
        5. Antibiotic Drugs
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Diagnostic labs
          1. By Value
        4. Research and Academic Institutes
          1. By Value
    7. Canada
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    6. U.K.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassays
          1. By Value
        3. Chromatography-Spectrometry
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Consumables
          1. By Value
        3. Equipment
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Antiepileptic Drugs
          1. By Value
        3. Antiarrhythmic Drugs
          1. By Value
        4. Immunosuppressant Drugs
          1. By Value
        5. Antibiotic Drugs
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Diagnostic labs
          1. By Value
        4. Research and Academic Institutes
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    6. China
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassays
          1. By Value
        3. Chromatography-Spectrometry
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Consumables
          1. By Value
        3. Equipment
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Antiepileptic Drugs
          1. By Value
        3. Antiarrhythmic Drugs
          1. By Value
        4. Immunosuppressant Drugs
          1. By Value
        5. Antibiotic Drugs
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Diagnostic labs
          1. By Value
        4. Research and Academic Institutes
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    6. UAE
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassays
          1. By Value
        3. Chromatography-Spectrometry
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Consumables
          1. By Value
        3. Equipment
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Antiepileptic Drugs
          1. By Value
        3. Antiarrhythmic Drugs
          1. By Value
        4. Immunosuppressant Drugs
          1. By Value
        5. Antibiotic Drugs
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Diagnostic labs
          1. By Value
        4. Research and Academic Institutes
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassays
        1. By Value
      3. Chromatography-Spectrometry
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Consumables
        1. By Value
      3. Equipment
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Antiepileptic Drugs
        1. By Value
      3. Antiarrhythmic Drugs
        1. By Value
      4. Immunosuppressant Drugs
        1. By Value
      5. Antibiotic Drugs
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Diagnostic labs
        1. By Value
      4. Research and Academic Institutes
        1. By Value
    6. Brazil
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassays
          1. By Value
        3. Chromatography-Spectrometry
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Consumables
          1. By Value
        3. Equipment
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Antiepileptic Drugs
          1. By Value
        3. Antiarrhythmic Drugs
          1. By Value
        4. Immunosuppressant Drugs
          1. By Value
        5. Antibiotic Drugs
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Diagnostic labs
          1. By Value
        4. Research and Academic Institutes
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Therapeutic Drug Monitoring Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbott Laboratories
    3. Danaher Corporation
    4. Biomerieux SA
    5. Chromsystems Instruments & Chemicals GmbH
    6. SEKISUI CHEMICAL CO., LTD.
    7. Bio-Rad Laboratories, Inc.
    8. Exagen Inc.
    9. Thermo Fisher Scientific Inc.
    10. Siemens AG
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.